Molecule Information
General Information of the Molecule (ID: Mol05640)
| Name |
SOX2-OT
,Homo sapiens
|
||||
|---|---|---|---|---|---|
| Molecule Type |
Long non-coding RNA
|
||||
| Sequence |
AAAAATGTTGAATATCAACAATGGGTTTCAGTGCTGTATTGTTGAGTTTTGTATGAACTA
ATCTAGCTTCTCTAAAAAAAAAAAAAAAAAAAAAAAAAAGAAAGAAAAGAAAGAAAGAAA AGAAAGAAAGAAAGAAAAAAAAAGAAAAGAAAAAAAAGAGAACCACAGCTTTGGACAAAA GTCTATAGCCAGTGCATTTGAAAACTCCCCTTGCACCAGGGCTGACTGTAGCTGGGGGAA GACATTTTACTCATTTGCTCTTTCCTTTCATACAGTCAGCTGGTCCCTCTTCTCAGGTGT AGATCACCTATTATAATTTTACCTAATTTTGATACTCTGATAAGGAAAGTCCCAGGACTT ATCAGCTGGGATAGGCCTCACTTACAAGACAGCTCTGTTCAGTATTTGGAAGAAAGCCTG ACAGGTTTCTTCGGAAAAGTGGCCATCCATGGAATGAATGAAATGTTCTCTTTCTATTCC AGGGATTGCAGTGGCAAAGCTAGGCTAGGTCTTGGAGGCTGGTGTAAGGCGATGTGGGTG AAGGCAGGAGGCTGATGGAAAGACTGGGGGGAAGAAAAGCCGAAATGGATTCACGGTGCC TTGGATGAAGGACGAGAGGGGAACTGCAAGCTCCTTCAACTGGTTCTGTCCGGTGAGAAG TGATCAAGCTTGGGCTGACAAGAGGCTCAGGGAGCCCTCACGTTCTTTCGCTTTTTTACC TGCCAATCAAACTGCTACAAGACAACACCCTGATCTGGCATGGACATCGCGGGTCCAAGC CTGTAGCCCCAAATCGGATAATCTCTGCAGCTGATAACAAGCAAAAGAGAAGCCAGGCAA CAGCCATATTAAAGAAGAAAACAATCAACTCTGAGATCCAACTTAGAAATAATGTTTCAT TCAAGATAAGGCTCGTGGCTTAGGAGATTGTGACCTGGCTTGCATCATTCTAAGACTTCT ATCGTCTGTTTTCAAAACCCAAGGAGGACCTCCTTTTCTGTGTGATAGTTCCTCATGCTT TGCCAGCCACTGGGTCTTTAAGGAAGCTTGCCAAGAGTTCCCGGCTGGGAAGGACAGTTC GAGTTCATCATAGACAATGAGCTGGCACCACAGTTTAAGTGACTCACCAACCTGGTTGCC CACTTCAAAATGTCAAGAACCACACTATCTAATTGAAAGAACTGTGTTTTAGCAAAGTGT AATTGGATCGCCTGGCAAGATCATCTCAAACTATGTCTCTGACCTTGCCTTTCAGTGGCT ATTTTGAGCACAAGAGGAGAAAGGAAATGATTCCTGAATTATATCTTGTTTTTAAAAATT AAGATTAATTAATACTTGGTTTTATGTTCATTCCATTGTAGGAACTTAGTGATTATTACA AAACAGTCAAAATAGGTCATAGCAAAATGAACGTTTAAGATTAGGTTAAAACATTCCTCT GAAATTTTAGTATTCACTTTTGAAGTGTCAATTACTATATTTCTGTAATTTCTCATTTTT TTCTTGGCTTAGAGTCAAGATGAAAAATGATATTTGAATCAAAGACATTGTTTTGTTATA TAGCCACTCCTTTCTAAAATGCAAATCCACCCTCCCCTCACCAATGCTTTATTCTTTGTG CGCGCACACACACACACACACACACACACACACACACACACACACAGACATACACAGAAC CAGCACCCAAATGGTAGAGGAGGTCCTTCCAAGACTTCTAGGACCTGGATCATGTAAGCA GTAGATGAGAAAATGAAGTAAGAGATATAGAGTAATAACAATAAAAGTCAATGATTTCAT TTTACAAAAAAGTCATTGTGTAGTACTCAGATATTTTTAAGAGCAAGTATTATTATGACT AAAGTATATTATACTTCTAAATTATTATGATTCTCATCTAATTTCAAGCCACACATAGGC GCCATTTGAAAGCATTTTGTGTTACAACCTATCAACAAAAATCAACTAATAGTTTTATAA CGTGCATAGGTTTACCCCATGGGGAATTAAAATTTTTATCTGCAAGTATTTCTGTTGTTG TGAGACTTTAGGACAAGACAACATTTGGTGTTAACATAGAAGAATATTCTATGGCTTTTT TAGCTTTAAAGTTCATTACTCTAAAATAAAGTACACGTGGTATTTTTTTCTTCCTAGTGT TCTCTTATTATATGTAGAGTATTTTCGGTTGTTGTTTTTAACGTATACATTATTTTTATT AAGTCATTTCATAAAAGATAAGATATATACTAATAGACCCTTGGTTTTCTCCTAATTTAA TTATTTCAAGTCAAGCAAAATTGGGCAATTTTCTTTCAGGAAAAAAAAAATATTGAGCAT GATTTTGAGGTAAAACTGATTATTTACAGCATCTTTTCTCTAATAGGCTAACATTTATGA TGGATCTTATTTCAAAGTTGATTATTCTCAAAGAAAAGTGGAGATATTAGAATTTCCGAG TAAATTGCATTGTTTTAAAAAGTACTTTAATGCATTGTTCACATTGTTGCCAGCTATTGA CCAAAAAAGAGAAGAAGAAAAAAGAAATAAAAAAAGCAGTATCTGCTCCAAACGTCAAGT TTTGCAGTTTGAAAGACTTGTACATTATAATTGTTTTTTTCTTTTTTGGAAAGCAGTAGT AATTAATACCAAAGGCATAGACAATTTAGGGCCATAACCTCCCTTCCCCCCTCTCCACCT TTTTTTTTTTTTTTTTTTTTTTTTAACTTTAACCATGATAGGCATCTCTGCAAGGTAGGT TTTAACATATTTTTTTCCTAATTTTTTTCCCTCCATTCAGTAAGAAGGATAAGCTTTTAG AGTACCCAGTCACCGTGGTAACTGCCAAAAAAATTCTCCTGAAGTTTGAAGAGGTCAGCT AGCAGGGTCAACAACCCTGGCCTCTCTCTGAGCTCGGTCTAGCATGCCCCAGCCTGCGGT TGGAGTGTCAGGCCAGATCTGACCCTGGGAGGTGGACCATTCTGGCTCTGATATAAATTT TTCGAGTCAGTTCATGGCCTGGACTCTCCAGGTGGCCTCCAAAATCGATTTTGACCCCCT GACCCTGTCTCACGGAGGCATAGCATCCACCCTAAGTAAGGATTTAGCCAGGAATGACAG CTTTCCACTGAGTGTTATTGGGGACAGTATAAACAGTTTGGAAAGCAAGTAAGGAGGTGT GAGGGCTAGCAATCATTAAAAGCACATTAAAAAACAATTTTTAAAAATCTTTATTAGAGA AAGTTGTAAATGCATATCTGTTACAGAATTCCTGTGATTTGTAGAGTTTTCTAGTCAGTT TTGAATATAAATAGGTCACATATCTTTATCTTTTTGCATACTTTGTTACAAATATGCAAA TAAGATAGGCATACTTGCTACAAAATAGGTACAGCAGGAATGTAATATGTTCAGAAAAGG CAAACTGGTTATTAAAACACATTAACAGGTAAGGAGTTTCTAATATTTTAAATACTAAAA TTTTACATGTGTATTTTGAAGTTTTTAAAATGGAAAAATAAAGAACCTTTAAAAA Click to Show/Hide
|
||||
| Click to Show/Hide the Complete Species Lineage | |||||
Type(s) of Resistant Mechanism of This Molecule
Drug Resistance Data Categorized by Drug
Approved Drug(s)
1 drug(s) in total
| Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
|
|
||||
| Disease Class: Glioblastoma [ICD-11: 2A00.02] | [1] | |||
| Resistant Disease | Glioblastoma [ICD-11: 2A00.02] | |||
| Resistant Drug | Temozolomide | |||
| Molecule Alteration | Expression | Up-regulation |
||
| Experimental Note | Revealed Based on the Cell Line Data | |||
| Cell Pathway Regulation | Wnt5a/beta-catenin signaling pathway | Regulation | N.A. | |
| In Vitro Model | U87 cells | Brain | Homo sapiens (Human) | CVCL_0022 |
| U251 cells | Brain | Homo sapiens (Human) | CVCL_0021 | |
| In Vivo Model | Glioblastoma patients; Nude mouse xenograft model | Homo sapiens | ||
| Experiment for Molecule Alteration |
RT-qPCR; Western blot; Immunohistochemistry staining; RNA pulldown assay; RNA immunoprecipitation assay; MeRIP-qPCR | |||
| Experiment for Drug Resistance |
CCK8 assay; Flow cytometric | |||
| Mechanism Description | Mechanistically, further investigation revealed that SOX2OT recruited ALKBH5, which binds with SOX2, demethylating the SOX2 transcript, leading to enhanced SOX2 expression. Together, these results demonstrated that LncRNA SOX2OT inhibited cell apoptosis, promoted cell proliferation, and TMZ resistance by upregulating SOX2 expression, which activated the Wnt5a/beta-catenin signaling pathway. | |||
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Yu.
